PUBLIC COMPANY
save$PTCPTC INC.
$PTC148.05+5.52%Boston, MA, USupdated 3h ago
community read0 votes
pipeline
3
marketed
2
phase 3
1
catalysts ytd
2
approvals ytd
0
recalls ytd
0
Pipeline(3)
pipeline depth3 products
1Phase 32Marketed
Upcoming
no upcoming catalysts on record
Recent(90d)
view all catalysts →Active trials
- phase3Long-Term Efficacy Study of Vatiquinone for the Treatment of Friedreich's Ataxia (FA)
- phase2A Study of SmartFlow Magnetic Resonance (MR) Compatible Ventricular Cannula for Administering Eladocagene Exuparvovec to Pediatric Participants
- phase3A Long-Term Safety Study of PTC923 in Participants With Phenylketonuria
- phase3A Study to Assess the Efficacy and Safety of Vatiquinone for the Treatment of Participants With Friedreich Ataxia
- phase3A Study to Evaluate Efficacy and Safety of Vatiquinone for Treating Mitochondrial Disease in Participants With Refractory Epilepsy
- phase3A Study of Sepiapterin in Participants With Phenylketonuria (PKU)
- phase3Long-Term Outcomes of Ataluren in Duchenne Muscular Dystrophy
- phase3Study of Ataluren in Previously Treated Participants With Nonsense Mutation Dystrophinopathy (nmDBMD)
🐶 Hiring Signal
News
no news has mentioned this company yet
Data sources
last refreshed 54m ago
Found something off?
comments(0)
5-min edit window · permanent after that